Literature DB >> 1642533

The catecholamine response to multisystem trauma.

P D Woolf1, J V McDonald, D V Feliciano, M M Kelly, D Nichols, C Cox.   

Abstract

We studied the catecholamine response in two groups of patients with multisystem injuries according to the presence (group 1, N = 124) or absence (group 2, N = 82) of head injury. Markers of injury severity included the injury Severity Score, the Glasgow Coma Scale, the need for intubation, admission hypotension, the amount of blood products and fluid expanders administered during the first 24 hours, and patient outcome. In group 1, higher norepinephrine levels always and epinephrine concentrations usually were associated with worsening indexes of injury severity. The best correlations were between the Injury Severity Score and the Glasgow Coma Scale and norepinephrine concentrations. In group 2, despite elevated catecholamine levels, such associations were seldom present. Thus, circulating catecholamine levels, especially norepinephrine levels, significantly correlated with the severity of injury in patients who had suffered multisystem injury, but only if the injury included the brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642533     DOI: 10.1001/archsurg.1992.01420080033005

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  28 in total

1.  Systemic hormonal, electrolyte, and substrate changes after non-thermal limb injury in children.

Authors:  T H Rainer; T Beattie; P Crofton; K Sedowofia; R Stephen; C Barclay; N McIntosh
Journal:  J Accid Emerg Med       Date:  1999-03

2.  The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin.

Authors:  P P Freestone; M Lyte; C P Neal; A F Maggs; R D Haigh; P H Williams
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

3.  Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing.

Authors:  Mohan R Dasu; Sandra R Ramirez; Thi Dinh La; Farzam Gorouhi; Chuong Nguyen; Benjamin R Lin; Chelcy Mashburn; Heather Stewart; Thomas R Peavy; Jan A Nolta; Roslyn R Isseroff
Journal:  Stem Cells Transl Med       Date:  2014-04-23       Impact factor: 6.940

4.  Clonidine reduces norepinephrine and improves bone marrow function in a rodent model of lung contusion, hemorrhagic shock, and chronic stress.

Authors:  Ines G Alamo; Kolenkode B Kannan; Harry Ramos; Tyler J Loftus; Philip A Efron; Alicia M Mohr
Journal:  Surgery       Date:  2016-10-11       Impact factor: 3.982

5.  Association of Early Hemodynamic Profile and the Development of Systolic Dysfunction Following Traumatic Brain Injury.

Authors:  Vijay Krishnamoorthy; Ali Rowhani-Rahbar; Nophanan Chaikittisilpa; Edward F Gibbons; Frederick P Rivara; Nancy R Temkin; Alex Quistberg; Monica S Vavilala
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

6.  Delayed resuscitation with physostigmine increases end organ damage in alcohol intoxicated rats.

Authors:  Jesse K Sulzer; Patricia E Molina
Journal:  Shock       Date:  2011-01       Impact factor: 3.454

7.  The Bordetella bfe system: growth and transcriptional response to siderophores, catechols, and neuroendocrine catecholamines.

Authors:  Mark T Anderson; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

8.  Norepinephrine-mediated suppression of phagocytosis by wound neutrophils.

Authors:  Ankush Gosain; Richard L Gamelli; Luisa A DiPietro
Journal:  J Surg Res       Date:  2008-06-02       Impact factor: 2.192

9.  Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.

Authors:  Hideki Yasui; Deborah L Donahue; Mark Walsh; Francis J Castellino; Victoria A Ploplis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

10.  Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients.

Authors:  Asko Riutta; Pauli Ylitalo; Seppo Kaukinen
Journal:  Intensive Care Med       Date:  2009-07-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.